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SUMMARY
Purpose: To consider the definition of acute symptomatic
seizures for epidemiological studies, and to refine the cri-
teria used to distinguish these seizures from unprovoked
seizures for specific etiologies.
Methods: Systematic review of the literature and of epi-
demiologic studies.
Results: An acute symptomatic seizure is defined as a clin-
ical seizure occurring at the time of a systemic insult or in
close temporal association with a documented brain
insult. Suggestions aremade to define acute symptomatic
seizures as those events occurring within 1 week of
stroke, traumatic brain injury, anoxic encephalopathy, or
intracranial surgery; at first identification of subdural
hematoma; at the presence of an active central nervous
system (CNS) infection; or during an active phase of mul-
tiple sclerosis or other autoimmune diseases. In addition,
a diagnosis of acute symptomatic seizure should be
made in the presence of severe metabolic derangements
(documented within 24 h by specific biochemical or
hematologic abnormalities), drug or alcohol intoxication
andwithdrawal, or exposure towell-defined epileptogenic
drugs.
Discussion: Acute symptomatic seizures must be
distinguished from unprovoked seizures and separately
categorized for epidemiologic purposes. These recom-
mendations are based upon the best available data at the
time of this report. Systematic studies should be under-
taken to better define the associations in question, with
special reference to metabolic and toxic insults, for which
the timewindow for the occurrence of an acute symptom-
atic seizure and the absolute values for toxic and meta-
bolic dysfunction still require a clear identification.
KEY WORDS: Epidemiology, Definition, Acute symp-
tomatic seizure.
Acute symptomatic seizure (also known as reactive sei-
zures, provoked seizures, and situation-related seizures)
occur at the time of a systemic insult or in close temporal
association with a documented brain insult (Commission on
Classification Terminology of the International League
Against Epilepsy, 1989; Hauser et al., 1991; Commission
on Epidemiology and Prognosis, International League
Against Epilepsy, 1993). This definition was created for use
in epidemiologic studies. Acute symptomatic seizures are
classified as ‘‘situation related seizures’’ in the Revised
Classification of Epilepsies and Epileptic Syndromes
(Commission on Classification and Terminology of the
International League Against Epilepsy, 1989), a category
also encompassing seizures for which there is no apparent
obvious cause. Recently, the International League Against
Epilepsy (ILAE) has defined epilepsy as ‘‘a disorder charac-
terized by an enduring predisposition to generate epileptic
seizures and by neurobiologic, cognitive, psychological and
social consequences of this condition. This definition
requires the occurrence of at least one epileptic seizure’’
(Fisher et al., 2005). ‘‘Enduring’’ is yet to be defined, but if
it includes people with structural brain lesions, the concept
would include most seizures traditionally considered acute
symptomatic. Because of difficulties in adapting this ILAE
definition to epidemiologic studies, the Commission on Epi-
demiology and Prognosis decided to retain the use of the
term acute symptomatic seizures as separate from the
unprovoked seizures that define epilepsy. Recent evidence
suggests that the prognosis of acute symptomatic seizures
differs from that of unprovoked seizures (Hesdorffer et al.,
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2009), further supporting the definition. We aim to provide
guidelines for determining the circumstances in which a sei-
zure should be classified as acute symptomatic for epidemi-
ologic studies. Not all potential etiologies are discussed,
because some potential causes of acute symptomatic sei-
zures are rare and unlikely to have a major impact upon epi-
demiologic studies. In addition, we do not address
prescribed drugs, although some have known association
with acute symptomatic seizures (Ruffmann et al., 2006).
This article results from a meeting held in November
2004 and subsequent teleconferences over the next two and
a half years. The commission developed definitions for each
category of acute symptomatic seizure to establish guide-
lines for epidemiologic research. Literature was reviewed
by the group and the results of those discussions are
reflected herein. The report has been endorsed by the ILAE
Executive Committee.
Acute symptomatic seizures differ from epilepsy in sev-
eral important aspects. First, unlike epilepsy, the proximate
cause of these seizures is clearly identifiable to the extent
one can ever be certain of a causal association. The close
temporal sequence makes causality likely for acute symp-
tomatic seizures in association with conditions such as head
injury or stroke, when they immediately precede or are con-
current with the seizure. Biologic plausibility also supports
causality, as illustrated by the acute disruption of brain
integrity or of metabolic homeostasis in association with the
insult. Often a dose effect exists, with more severe injury
leading to a higher risk of seizures. Although risk ratios have
not been calculated, they are likely enormous. Second,
unlike epilepsy, acute symptomatic seizures are not neces-
sarily characterized by a tendency for recurrence, exempting
them from the new definition’s criteria of enduring predis-
position to seize. Although individuals experiencing such
insults are sometimes at an increased risk for developing
epilepsy in the future, acute symptomatic seizures are unli-
kely to recur unless the underlying acute causal condition
recurs (Hesdorffer et al., 1998). As a corollary, most indi-
viduals need not be treated on a long-term basis with antisei-
zure medication, although such treatment may be warranted
on a short-term basis until the acute condition is resolved.
People with epilepsy can also experience an acute symp-
tomatic seizure. Whether they are more likely to have such
an episode in association with a specific insult is a point for
future study. In our opinion, provoked seizures and situa-
tion-related seizures are synonyms for acute symptomatic
seizures. Reflex epilepsy and photosensitive epilepsy are
distinct entities defined by the response to precipitants.
Sleep deprivation has been insufficiently studied as a sei-
zure precipitant in individuals without epilepsy or as a risk
factor for seizures in people with epilepsy. Although the cri-
teria for acute symptomatic seizures are somewhat arbitrary,
this is a first attempt to codify the levels of risk associated
with a broad spectrum of insults.
Few epidemiologic studies report the frequency of acute
symptomatic seizures, but when reported, these seizures
account for 34% of all afebrile seizures (Hauser et al.,
1996). Adding febrile seizures increases this percentage to
roughly 55% of all seizures (Hauser et al., 1996). Differ-
ences in the proportion of people with acute symptomatic
seizures across studies may result from difficulties in their
definition. Such seizures are seldom indexed as a diagno-
sis—rather a diagnosis of the underlying condition is likely
to be coded, making studies relying on seizure ICD codes
inefficient, with probable gross under enumeration. Further-
more, these individuals are seldom referred for long-term
follow-up to neurologists and, given the acute nature of the
underlying insult, an electroencephalographic evaluation
may not be warranted or appropriate, thus eliminating these
sources of case identification. In studies relying on field sur-
veys, a moderate amount of sophistication is necessary to
distinguish acute symptomatic seizures from unprovoked
seizures. Therefore, although the causation and prognosis of
acute symptomatic seizures differ from epilepsy, some epi-
demiologic studies have included such seizures as ‘‘epi-
lepsy’’ (Placencia et al., 1992), or failed to distinguish these
from unprovoked seizures (Luhdorf et al., 1986).
Distinction between
Unprovoked Seizures and Acute
Symptomatic Seizures
This report develops definitions to differentiate acute
symptomatic seizures from unprovoked seizures in order to
systematically classify cases and determine prognosis.
Definition of acute symptomatic seizures
Acute symptomatic seizures are events, occurring in
close temporal relationship with an acute CNS insult, which
may be metabolic, toxic, structural, infectious, or due to
inflammation. The interval between the insult and the sei-
zure may vary according to the underlying clinical condition
(see subsequent text). The term acute symptomatic seizure
should be used instead of provoked seizure, reactive seizure,
or situation-related seizure.
Definition of unprovoked seizures/epilepsy
Unprovoked seizures are defined as seizures occurring in
the absence of a potentially responsible clinical condition or
beyond the interval estimated for the occurrence of acute
symptomatic seizures. Unprovoked seizures differ from
acute symptomatic seizures in risk of seizure recurrence and
mortality for several etiologies.
Misclassification of acute symptomatic seizures
Misclassification of acute symptomatic seizures as
unprovoked seizures can occur, because the age distribution
of incident seizures is similar and acute symptomatic
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seizures are almost as frequent as epilepsy (Loiseau et al.,
1990; Hauser et al., 1991; Annegers et al., 1995). The chal-
lenge is to identify the acute symptomatic seizures and sepa-
rately define unprovoked seizures, particularly problematic
in resource-poor settings, but also difficult elsewhere.
Factors excluded from consideration in this document
We do not consider factors that may induce seizures in
people with documented epilepsy, such as sleep deprivation
and photic stimulation.
General rules
Seizure in the setting of two causes where one cause would
classify the seizure as acute symptomatic
Seizures occurring in the setting of an acute insult associ-
ated with events where there is also a remote symptomatic
etiology should be classified as acute symptomatic seizure,
because it is the more proximate cause. For example, a sei-
zure occurring in association with an acute stroke where
there is also an old traumatic brain injury (TBI) should be
classified as acute symptomatic due to the acute stroke. If a
person has preexisting epilepsy, a seizure that meets criteria
for acute symptomatic will still be so classified.
Specific Causes of Acute
Symptomatic Seizures
Ideally acute symptomatic seizures related to structural
or metabolic changes associated with an acute CNS insult
(i.e., stroke or traumatic brain injury) are categorized sepa-
rately from unprovoked seizures occurring after stabiliza-
tion. This definition is biologically plausible because acute
symptomatic seizures and unprovoked seizures have differ-
ent prognoses (Hesdorffer et al., 2009). Seizures are consid-
ered acute symptomatic if they occur within the first 7 days
of cerebrovascular disease (Jennett et al., 1973; Camilo &
Goldstein, 2004); TBI, including intracranial surgery (Jen-
nett et al., 1973; Annegers et al., 1998); and CNS infections
(Annegers et al., 1988). For TBI, longer intervals are
acceptable for subdural hematoma without known trauma
when the hematoma is identified. Similarly, seizures in
association with arteriovenous malformations are acute
symptomatic during the acute hemorrhage. For CNS infec-
tions, acute symptomatic seizures can occur beyond 7 days,
with persistent clinical or laboratory findings. Acute symp-
tomatic seizures occur in the setting of several infectious
diseases: when imaging identifies at least one parasite in the
transitional or degenerative phase for neurocysticercosis,
when malaria is accompanied by fever, during treatment of
cerebral tuberculoma and brain abscess, and during acute
infection or severe metabolic disturbance in HIV infection.
In multiple sclerosis, acute symptomatic seizures occur as
the first presenting symptom or within 7 days of relapse.
Such seizures also occur in autoimmune diseases when
signs or symptoms of activation are noted. All seizures
occurring with congenital toxoplasmosis and with Creutz-
feldt-Jacob disease are remote symptomatic, and those
occurring in degenerative diseases of the elderly are pro-
gressive symptomatic.
Acute symptomatic seizures in association with
metabolic, toxic, and other systemic illness
Metabolic conditions that provoke seizures: Alterations
of metabolic homeostasis are associated with seizures in
many situations. Our approach to cutoffs for metabolic
abnormalities has been to favor specificity over sensitivity,
thus reducing the false positives (those whose seizures were
really not due to the metabolic disturbance). The propensity
of metabolic disturbances to cause seizures may depend on
the rapidity with which the disturbance develops: the more
rapid the more likely it is to induce seizures (Riggs, 2002).
The blood sample upon which classification is based should
reflect the time of the seizure, operationally within 24 h of
the seizure, so that it is logical to assume that the findings
are similar to those at the time of the seizure.
In a literature search of studies of metabolic disorders and
seizures or status epilepticus, only case studies were found,
and in these the biochemical abnormalities were mostly
reported as group means with standard deviations. In the
absence of clear data on cutoffs, we have provided cutoffs at
the extreme end of abnormalities until future studies provide
better information (Table 1). The cutoffs are arbitrary and
are only supported to some extent by the literature (Riggs,
2002; Castilla-Guerra et al., 2006; Posner et al., 2007).
When there is suspicion that the seizure may be acute symp-
tomatic due to a metabolic derangement but the proposed
cutoffs are not met, seizures should not be classified as acute
symptomatic. This does not mean that they should be classi-
fied as unprovoked. Instead, they will likely be placed into
an ‘‘unknown’’ category, but excluded as epilepsy. Better
cutoffs will require specific studies in the future.
Cerebral hypoxia
Similar to cerebrovascular disease, seizures occurring
within 1 week of anoxic encephalopathy should be classi-
fied as acute symptomatic, until further information is
available.
Seizures associated with drugs and toxic substances
Alcohol
Alcohol and drug withdrawal and alcohol intoxication.
The following are considered appropriate indicators of acute
symptomatic seizures associated with alcohol withdrawal:
history of chronic alcohol abuse, history of current alcohol
use with recent reduction in consumption, and generalized
tonic–clonic seizure with other symptoms of withdrawal
such as tremors, sweats, or tachycardia. The seizure must
occur within 7–48 h of the last drink. If there is a history of
673
Definition of Acute Symptomatic Seizure
Epilepsia, 51(4):671–675, 2010
doi: 10.1111/j.1528-1167.2009.02285.x
recent alcohol abuse without a known history of chronic
alcohol abuse, then clinical judgment should determine
whether the seizure was due to alcohol withdrawal. Seizures
in the setting of acute alcohol intoxication (Hillbom et al.,
2003; Brathen et al., 2005) (due to extremely high quanti-
ties consumed) are likely associated with that exposure.
Acute symptomatic seizures also occur with withdrawal of
barbiturates and of benzodiazepines.
Illicit drugs
Seizures are considered acute symptomatic based upon
the probability of seizure occurrence for specific drugs.
There is high probability for cocaine and crack if metabolites
are found in urine or blood; Normeperidine; meperidine;
Methaqualone; Glutarimide; stimulants (e.g., methylenedi-
oxymethamphetamine) taken in excess; and inhalants. There
is fair probability for hallucinogens; angel dust (PCP, Phen-
cyclidine) (phencyclidine and quatadine). There is low or no
probability for heroin and for marijuana.
Seizures associated with febrile illness
Febrile seizures in children are well described, although
the temperature for inclusion varies. We suggest that the
minimum rectal temperature be 38.5C (101.0F) (Berg
et al., 1992), which may be modified if fever reduction is
attempted using antipyretic drugs or other measures.
Although first febrile seizures are rare after the age of 5, epi-
demiologic data suggest that there should not be an upper
age limit for the occurrence of febrile seizures in childhood.
Future Activities
The preceding criteria are guidelines for the classification
of seizures as acute symptomatic. Each recommendation is
based upon the best available data at the time of this report.
It is suggested that systematic studies be undertaken to
better define each of the associations in question. For neuro-
logic insults, further definition of timing of seizures in rela-
tion to the acute event is necessary, and further refinement
may be possible after taking into account clinical factors
associated with neurologic insults (i.e., severity of trauma
for head injury; area of the lesion for cerebrovascular dis-
ease). For metabolic and toxic insults, further work is
needed to clarify the time window in which an acute symp-
tomatic seizure can occur as well as the absolute values for
metabolic and toxic dysfunction. Additional work is also
needed to further understand the prognosis of this subgroup
of seizures.
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